Y. ASLAN Et Al. , "Is the presence of metabolic syndrome important for predicting the efficacy of the treatment of doksazosin 4 mg and 8 mg.," 16th Congress of European Society of Sexual Medicin , İstanbul, Turkey, 2014
ASLAN, Y. Et Al. 2014. Is the presence of metabolic syndrome important for predicting the efficacy of the treatment of doksazosin 4 mg and 8 mg.. 16th Congress of European Society of Sexual Medicin , (İstanbul, Turkey).
ASLAN, Y., TUNCEL, A., & ATAN, A., (2014). Is the presence of metabolic syndrome important for predicting the efficacy of the treatment of doksazosin 4 mg and 8 mg. . 16th Congress of European Society of Sexual Medicin, İstanbul, Turkey
ASLAN, YILMAZ, ALTUĞ TUNCEL, And ALİ ATAN. "Is the presence of metabolic syndrome important for predicting the efficacy of the treatment of doksazosin 4 mg and 8 mg.," 16th Congress of European Society of Sexual Medicin, İstanbul, Turkey, 2014
ASLAN, YILMAZ Et Al. "Is the presence of metabolic syndrome important for predicting the efficacy of the treatment of doksazosin 4 mg and 8 mg.." 16th Congress of European Society of Sexual Medicin , İstanbul, Turkey, 2014
ASLAN, Y. TUNCEL, A. And ATAN, A. (2014) . "Is the presence of metabolic syndrome important for predicting the efficacy of the treatment of doksazosin 4 mg and 8 mg.." 16th Congress of European Society of Sexual Medicin , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={YILMAZ ASLAN Et Al. }, title={Is the presence of metabolic syndrome important for predicting the efficacy of the treatment of doksazosin 4 mg and 8 mg.}, congress name={16th Congress of European Society of Sexual Medicin}, city={İstanbul}, country={Turkey}, year={2014}}